The 22nd Bio鈧琿uity Europe
16-18 May, 2022
Milan, Italy
51萝莉 will attend the 22nd Bio鈧琿uity Europe, the Europe鈥檚 premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs.
51萝莉鈥檚 team will reconnect with investors and partners to accelerate the clinical development of its lead compound Vonafexor focused on kidney and liver diseases.
Jacky Vonderscher will also present 鈥淰ONAFEXOR, a fibrolytic and anti-inflammatory for the treatment of kidney and liver diseases鈥� in the Hot Topics Track #1 session, 16:30 pm -16:42 pm, May 17
Latest Press Release 